SynthesisFrontiers in cardiovascular medicine2023

Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis.

Zhenzhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.